 | • レポートコード：MRC2-11QY12757 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗結核治療薬のグローバル市場について調査・分析したレポートです。種類別（一次抗結核薬、二次抗結核薬）市場規模、用途別（活動性結核、潜在性結核）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗結核治療薬の競争状況、市場シェア ・世界の抗結核治療薬市場：種類別市場規模 2015年-2020年（一次抗結核薬、二次抗結核薬） ・世界の抗結核治療薬市場：種類別市場規模予測 2021年-2026年（一次抗結核薬、二次抗結核薬） ・世界の抗結核治療薬市場：用途別市場規模 2015年-2020年（活動性結核、潜在性結核） ・世界の抗結核治療薬市場：用途別市場規模予測 2021年-2026年（活動性結核、潜在性結核） ・北米の抗結核治療薬市場分析：米国、カナダ ・ヨーロッパの抗結核治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗結核治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗結核治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗結核治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Lupin、Otsuka Novel Products、Pfizer、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.
Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.
Market Analysis and Insights: Global Tuberculosis Drug Market
The global Tuberculosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tuberculosis Drug Scope and Market Size
Tuberculosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tuberculosis Drug market is segmented into
First-line Anti-TB Drugs
Second-line Anti-TB Drugs
Segment by Application, the Tuberculosis Drug market is segmented into
Active TB
Latent TB
Regional and Country-level Analysis
The Tuberculosis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tuberculosis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tuberculosis Drug Market Share Analysis
Tuberculosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tuberculosis Drug business, the date to enter into the Tuberculosis Drug market, Tuberculosis Drug product introduction, recent developments, etc.
The major vendors covered:
Lupin
Otsuka Novel Products
Pfizer
Sanofi
…
1 Study Coverage
1.1 Tuberculosis Drug Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Drug Market Size Growth Rate by Type
1.4.2 First-line Anti-TB Drugs
1.4.3 Second-line Anti-TB Drugs
1.5 Market by Application
1.5.1 Global Tuberculosis Drug Market Size Growth Rate by Application
1.5.2 Active TB
1.5.3 Latent TB
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Drug Revenue 2015-2026
2.1.2 Global Tuberculosis Drug Sales 2015-2026
2.2 Global Tuberculosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tuberculosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tuberculosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tuberculosis Drug Competitor Landscape by Players
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Tuberculosis Drug Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Drug Revenue in 2019
3.2.5 Global Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Tuberculosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Drug Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Drug Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Drug Revenue by Type (2015-2020)
4.1.3 Tuberculosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Drug Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Drug Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Drug Revenue by Application (2015-2020)
5.1.3 Tuberculosis Drug Price by Application (2015-2020)
5.2 Tuberculosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Drug by Country
6.1.1 North America Tuberculosis Drug Sales by Country
6.1.2 North America Tuberculosis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tuberculosis Drug Market Facts & Figures by Type
6.3 North America Tuberculosis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Tuberculosis Drug by Country
7.1.1 Europe Tuberculosis Drug Sales by Country
7.1.2 Europe Tuberculosis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Drug Market Facts & Figures by Type
7.3 Europe Tuberculosis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Drug by Region
8.1.1 Asia Pacific Tuberculosis Drug Sales by Region
8.1.2 Asia Pacific Tuberculosis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tuberculosis Drug Market Facts & Figures by Type
8.3 Asia Pacific Tuberculosis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tuberculosis Drug by Country
9.1.1 Latin America Tuberculosis Drug Sales by Country
9.1.2 Latin America Tuberculosis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tuberculosis Drug Market Facts & Figures by Type
9.3 Central & South America Tuberculosis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Drug by Country
10.1.1 Middle East and Africa Tuberculosis Drug Sales by Country
10.1.2 Middle East and Africa Tuberculosis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tuberculosis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Tuberculosis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Lupin
11.1.1 Lupin Corporation Information
11.1.2 Lupin Description and Business Overview
11.1.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Tuberculosis Drug Products Offered
11.1.5 Lupin Related Developments
11.2 Otsuka Novel Products
11.2.1 Otsuka Novel Products Corporation Information
11.2.2 Otsuka Novel Products Description and Business Overview
11.2.3 Otsuka Novel Products Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Otsuka Novel Products Tuberculosis Drug Products Offered
11.2.5 Otsuka Novel Products Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Tuberculosis Drug Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Tuberculosis Drug Products Offered
11.4.5 Sanofi Related Developments
11.1 Lupin
11.1.1 Lupin Corporation Information
11.1.2 Lupin Description and Business Overview
11.1.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Tuberculosis Drug Products Offered
11.1.5 Lupin Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tuberculosis Drug Market Estimates and Projections by Region
12.1.1 Global Tuberculosis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Tuberculosis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Tuberculosis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Tuberculosis Drug Sales Forecast (2021-2026)
12.2.2 North America: Tuberculosis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Tuberculosis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Tuberculosis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Tuberculosis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tuberculosis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tuberculosis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tuberculosis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tuberculosis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Tuberculosis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Tuberculosis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Tuberculosis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tuberculosis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tuberculosis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tuberculosis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tuberculosis Drug Market Segments
Table 2. Ranking of Global Top Tuberculosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of First-line Anti-TB Drugs
Table 5. Major Manufacturers of Second-line Anti-TB Drugs
Table 6. Global Tuberculosis Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Tuberculosis Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Tuberculosis Drug Sales by Regions 2015-2020 (K MT)
Table 9. Global Tuberculosis Drug Sales Market Share by Regions (2015-2020)
Table 10. Global Tuberculosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Tuberculosis Drug Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Tuberculosis Drug Sales Share by Manufacturers (2015-2020)
Table 13. Global Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Tuberculosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Drug as of 2019)
Table 15. Tuberculosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Tuberculosis Drug Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Tuberculosis Drug Price (2015-2020) (USD/MT)
Table 18. Tuberculosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Tuberculosis Drug Product Type
Table 20. Date of International Manufacturers Enter into Tuberculosis Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 23. Global Tuberculosis Drug Sales Share by Type (2015-2020)
Table 24. Global Tuberculosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Tuberculosis Drug Revenue Share by Type (2015-2020)
Table 26. Tuberculosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 28. Global Tuberculosis Drug Sales Share by Application (2015-2020)
Table 29. North America Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 30. North America Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 31. North America Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 33. North America Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 34. North America Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 35. North America Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 36. North America Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 37. Europe Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 38. Europe Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 39. Europe Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 41. Europe Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 42. Europe Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 43. Europe Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 44. Europe Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Tuberculosis Drug Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Tuberculosis Drug Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Tuberculosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Tuberculosis Drug Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 53. Latin America Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 54. Latin America Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 57. Latin America Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 58. Latin America Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 59. Latin America Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 60. Latin America Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 69. Lupin Corporation Information
Table 70. Lupin Description and Major Businesses
Table 71. Lupin Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Lupin Product
Table 73. Lupin Recent Development
Table 74. Otsuka Novel Products Corporation Information
Table 75. Otsuka Novel Products Description and Major Businesses
Table 76. Otsuka Novel Products Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Otsuka Novel Products Product
Table 78. Otsuka Novel Products Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Global Tuberculosis Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 90. Global Tuberculosis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Tuberculosis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Tuberculosis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 94. North America: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 96. Europe: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Tuberculosis Drug Sales Forecast by Region (2021-2026) (K MT)
Table 98. Asia Pacific: Tuberculosis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 100. Latin America: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 102. Middle East and Africa: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Tuberculosis Drug Players
Table 107. Tuberculosis Drug Customers List
Table 108. Tuberculosis Drug Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Drug Product Picture
Figure 2. Global Tuberculosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. First-line Anti-TB Drugs Product Picture
Figure 4. Second-line Anti-TB Drugs Product Picture
Figure 5. Global Tuberculosis Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Active TB
Figure 7. Latent TB
Figure 8. Tuberculosis Drug Report Years Considered
Figure 9. Global Tuberculosis Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Tuberculosis Drug Sales 2015-2026 (K MT)
Figure 11. Global Tuberculosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Tuberculosis Drug Sales Market Share by Region (2015-2020)
Figure 13. Global Tuberculosis Drug Sales Market Share by Region in 2019
Figure 14. Global Tuberculosis Drug Revenue Market Share by Region (2015-2020)
Figure 15. Global Tuberculosis Drug Revenue Market Share by Region in 2019
Figure 16. Global Tuberculosis Drug Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis Drug Revenue in 2019
Figure 18. Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Tuberculosis Drug Sales Market Share by Type (2015-2020)
Figure 20. Global Tuberculosis Drug Sales Market Share by Type in 2019
Figure 21. Global Tuberculosis Drug Revenue Market Share by Type (2015-2020)
Figure 22. Global Tuberculosis Drug Revenue Market Share by Type in 2019
Figure 23. Global Tuberculosis Drug Market Share by Price Range (2015-2020)
Figure 24. Global Tuberculosis Drug Sales Market Share by Application (2015-2020)
Figure 25. Global Tuberculosis Drug Sales Market Share by Application in 2019
Figure 26. Global Tuberculosis Drug Revenue Market Share by Application (2015-2020)
Figure 27. Global Tuberculosis Drug Revenue Market Share by Application in 2019
Figure 28. North America Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Tuberculosis Drug Sales Market Share by Country in 2019
Figure 31. North America Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 32. U.S. Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Tuberculosis Drug Market Share by Type in 2019
Figure 37. North America Tuberculosis Drug Market Share by Application in 2019
Figure 38. Europe Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Tuberculosis Drug Sales Market Share by Country in 2019
Figure 41. Europe Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 42. Germany Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Tuberculosis Drug Market Share by Type in 2019
Figure 53. Europe Tuberculosis Drug Market Share by Application in 2019
Figure 54. Asia Pacific Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Tuberculosis Drug Sales Market Share by Region in 2019
Figure 57. Asia Pacific Tuberculosis Drug Revenue Market Share by Region in 2019
Figure 58. China Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Tuberculosis Drug Market Share by Type in 2019
Figure 81. Asia Pacific Tuberculosis Drug Market Share by Application in 2019
Figure 82. Latin America Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Tuberculosis Drug Sales Market Share by Country in 2019
Figure 85. Latin America Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 86. Mexico Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Tuberculosis Drug Market Share by Type in 2019
Figure 93. Latin America Tuberculosis Drug Market Share by Application in 2019
Figure 94. Middle East and Africa Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Tuberculosis Drug Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 98. Turkey Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Tuberculosis Drug Market Share by Type in 2019
Figure 105. Middle East and Africa Tuberculosis Drug Market Share by Application in 2019
Figure 106. North America Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
結核治療薬の世界市場（～2026年） Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Market Analysis and Insight…- 結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…
- 結核治療の世界市場（～2026年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tuberculosis Treatment Scope and Market Size Tuberculosis Treatment m…
- 結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …